Has This Hot Med Tech Market Frozen Over?
Renal denervation's a huge opportunity for Medtronic, St. Jude Medical, and other leading device companies, but recent setbacks have investors wondering how long it will be before potential translates into results
3 Ways Johnson & Johnson Is Revolutionizing Diabetes Care
Johnson & Johnson rarely gets much attention for its efforts in diabetes treatments. Let’s take a look at three of the company’s interesting new efforts to treat diabetes, and how they could affect companies like AstraZeneca, Bristol-Myers Squibb, Medtronic, DexCom, and Sanofi.
This Health Care Giant's Biggest Opportunity Isn't in America
Here's how Covidien's latest buys highlight the huge opportunities abroad that Stryker, Medtronic, and other device firms are racing to take advantage of.
Will Cardiac Device Stocks Have a Pulse in 2014?
Boston Scientific, St. Jude Medical, and Medtronic put on a show for investors in 2013, but can they keep up their momentum in the new year?
Medtronic's Surprising Update Spikes Blood Pressures Across Med-Tech
A potential $3 billion/year therapy may not work nearly as well as hoped.
3 Stocks Near 52-Week Highs Worth Selling
Are these three stocks sells or belles? You be the judge!
NuVasive, Inc: The Best Medical Device Companies of 2013
Fewer complications and faster recovery times support demand for NuVasive's minimally invasive spine surgery products.